Impact of molecular ciprofloxacin resistance testing in management of gonorrhoea in a large urban clinic.
CIPROFLOXACIN
Drug Resistance, Bacterial
Gonorrhea
Molecular Diagnostic Techniques
NEISSERIA GONORRHOEAE
Journal
Sexually transmitted infections
ISSN: 1472-3263
Titre abrégé: Sex Transm Infect
Pays: England
ID NLM: 9805554
Informations de publication
Date de publication:
03 May 2024
03 May 2024
Historique:
received:
28
12
2023
accepted:
21
04
2024
medline:
4
5
2024
pubmed:
4
5
2024
entrez:
3
5
2024
Statut:
aheadofprint
Résumé
Antibiotic resistance in gonorrhoea is of significant public health concern with the emergence of resistance to last-line therapies such as ceftriaxone. Despite around half of Molecular ciprofloxacin resistance testing ( A total of 998 clinical samples tested positive for In routine practice in a large UK clinic, molecular ciprofloxacin resistance testing led to a significant shift in antibiotic use, reducing use of ceftriaxone. Testing can be targeted to reduce unnecessary additional testing. Longer term impact on antimicrobial resistance requires ongoing surveillance.
Identifiants
pubmed: 38702191
pii: sextrans-2023-056099
doi: 10.1136/sextrans-2023-056099
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.